Opportunistic salpingectomy: Uptake, risks, and complications of a regional initiative for ovarian cancer prevention

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 5, 2014, Pages 471.e1-471.e11

  McAlpine, Jessica N ^a   Hanley, Gillian E ^c   Woo, Michelle M M ^b,e   Tone, Alicia A ^d   Rozenberg, Nirit ^e   Swenerton, Kenneth D ^a   Gilks, C Blake ^b   Finlayson, Sarah J ^a   Huntsman, David G ^b,e   Miller, Dianne M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

educational campaign; ovarian cancer; prevention; safety; salpingectomy

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BILATERAL SALPINGECTOMY; BLOOD TRANSFUSION; CANADA; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMALE STERILIZATION; FIMBRIECTOMY; GYNECOLOGIC SURGERY; GYNECOLOGIST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYSTERECTOMY; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MIDDLE AGED; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVARIECTOMY; OVARY CANCER; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SALPINGECTOMY; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; TREATMENT INDICATION; UTERINE TUBE LIGATION;

EDUCATIONAL CAMPAIGN; OVARIAN CANCER; PREVENTION; SAFETY; SALPINGECTOMY;

ADOLESCENT; ADULT; BRITISH COLUMBIA; EDUCATION, MEDICAL, CONTINUING; FALLOPIAN TUBES; FEMALE; GYNECOLOGY; HUMANS; HYSTERECTOMY; ODDS RATIO; OPERATIVE TIME; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SALPINGECTOMY; STERILIZATION, TUBAL; YOUNG ADULT;

EID: 84899751361     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.01.003     Document Type: Article

References (34)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. H. Kobayashi, Y. Yamada, and T. Sado et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan Int J Gynecol Cancer 18 2008 414 420
3. S.S. Buys, E. Partridge, and A. Black et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled trial JAMA 305 2011 2295 2303
4. U. Menon, A. Gentry-Maharaj, and R. Hallett et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 2009 327 340
5. N.M. Van der Velde, M.J. Mourits, and H.J. Arts et al. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 2009 919 923
6. E.R. Woodward, H.V. Sleightholme, A.M. Considine, S. Williamson, J.M. McHugo, and D.G. Cruger Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective BJOG 114 2007 1500 1509
7. Surveillance Epidemiology and End Results. Surveillance Epidemiology and End Results (SEER) Cancer Statistics Review 1975-2010 Available at: http://seer.cancer.gov. Accessed May 22, 2013.
8. Ovarian Cancer Research Program of BC, Cheryl Brown Ovarian Cancer Outcomes Unit. OVCARE: research platforms, 2013. Available at: www.ovcare.ca. Accessed Feb 6, 2014.
9. C.B. Gilks, D.N. Ionescu, and S.E. Kalloger et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma Hum Pathol 39 2008 1239 1251
10. R.J. Kurman, and IeM. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer: shifting the paradigm Hum Pathol 42 2011 918 931
11. J.W. Carlson, A. Miron, and E.A. Jarboe et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 2008 4160 4165
12. J.D. Seidman, P. Zhao, and A. Yemelyanova "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol Oncol 120 2011 470 473
13. S. Salvador, B. Gilks, M. Kobel, D. Huntsman, B. Rosen, and D. Miller The fallopian tube: primary site of most pelvic high-grade serous carcinomas Int J Gynecol Cancer 19 2009 58 64
14. S. Salvador, A. Rempel, R.A. Soslow, B. Gilks, D. Huntsman, and D. Miller Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma Gynecol Oncol 110 2008 408 417
15. F. Medeiros, M.G. Muto, and Y. Lee et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
16. A.M. Karst, K. Levanon, and R. Drapkin Modeling high-grade serous ovarian carcinogenesis from the fallopian tube Proc Natl Acad Sci U S A 108 2011 7547 7552
17. N. Auersperg The origin of ovarian cancers: hypotheses and controversies Front Biosci 5 2013 709 719
18. D.W. Kindelberger, Y. Lee, and A. Miron et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169
19. M.S. Anglesio, M.S. Carey, M. Kobel, H. Mackay, D.G. Huntsman Vancouver Ovarian Clear Cell Symposium Speakers Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010 Gynecol Oncol 121 2011 407 415
20. C.L. Pearce, C. Templeman, and M.A. Rossing et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies Lancet Oncol 13 2012 385 394
21. M.A. Rossing, K.L. Cushing-Haugen, K.G. Wicklund, J.A. Doherty, and N.S. Weiss Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery Cancer Causes Control 19 2008 1357 1364
22. A.A. Tone, S. Salvador, and S.J. Finlayson et al. The role of the fallopian tube in ovarian cancer Clin Advances Hematol Oncol 10 2012 296 306
23. W. Sieh, S. Salvador, and V. McGuire et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies Int J Epidemiol 42 2013 579 589
24. D. Vicus, A. Finch, and B. Rosen et al. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation Gynecol Oncol 118 2010 155 159
25. S.A. Narod, P. Sun, and P. Ghadirian et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study Lancet 357 2001 1467 1470
26. S.M. Domchek, T.M. Friebel, and S.L. Neuhausen et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 2006 223 229
27. W.H. Parker, M.S. Broder, and E. Chang et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study Obstet Gynecol 113 2009 1027 1037
28. W.H. Parker, D. Feskanich, and M.S. Broder et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study Obstet Gynecol 121 2013 709 716
29. D. Juurlink, C. Preyra, and R. Croxford et al. Canadian Institute for Health Information Discharge Abstract Database: a validation study 2006 Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada
30. McAlpine JN, Tone AA, Huntsman DG, Miller DM, Finlayson SJ. Risk-reducing salpingectomy in low risk patients: assessing the impact of a novel request for surgical practice change. Int J Gynecol Cancer 2012;22:E326.
31. C.J. Reade, S. Finlayson, J. McAlpine, A.A. Tone, M. Fung-Kee-Fung, and S.E. Ferguson Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists J Obstet Gynaecol Can 35 2013 627 634
32. C. Sandoval, M. Fung-Kee-Fung, B. Gilks, K.J. Murphy, R. Rahal, and H. Bryant Examining the use of salpingectomy with hysterectomy in Canada Curr Oncol 20 2013 173 175
33. M. Morelli, R. Venturella, and R. Mocciaro et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecol Oncol 129 2013 448 451
34. C. Lessard-Anderson, R. Molitor, and J. St. Sauver et al. The impact of tubal sterilization techniques on the risk of serous ovarian and primary peritoneal carcinoma: a Rochester Epidemiology Project (REP) study Gynecol Oncol 130 2013 e25 6